Literature DB >> 18720098

Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats.

Changping Yao1, Anthony J Williams, Andrew K Ottens, X-C May Lu, Renwu Chen, Kevin K Wang, Ronald L Hayes, Frank C Tortella, Jitendra R Dave.   

Abstract

PRIMARY
OBJECTIVE: Recent efforts have been aimed at developing a panel of protein biomarkers for the diagnosis/prognosis of the neurological damage associated with acute brain injury. METHODS AND PROCEDURES: This study utilized high-throughput immunoblotting (HTPI) technology to compare changes between two animal models of acute brain injury: penetrating ballistic-like brain injury (PBBI) which mimics the injury created by a gunshot wound and transient middle cerebral artery occlusion (MCAo) which is a model of stroke. Brain and blood were collected at 24-hours post-injury. MAIN OUTCOMES AND
RESULTS: This study identified the changes in 18 proteins following PBBI and 17 proteins following MCAo out of a total of 998 screened proteins. Distinct differences were observed between the two models: five proteins were up- or down-regulated in both models, 23 proteins changed in only one model and one protein was differentially expressed. Western blots were used to verify HTPI results for selected proteins with measurable changes observed in both blood and brain for the proteins STAT3, Tau, PKA RII beta, 14-3-3 epsilon and p43/EMAPII.
CONCLUSIONS: These results suggest distinct post-injury protein profiles between brain injury types (traumatic vs. ischemic) that will facilitate strategies aimed at the differential diagnosis and prognosis of acute brain injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18720098     DOI: 10.1080/02699050802304706

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  13 in total

Review 1.  Blood-based diagnostics of traumatic brain injuries.

Authors:  Stefania Mondello; Uwe Muller; Andreas Jeromin; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

2.  Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury.

Authors:  Sumit Bhattacharyya; Xiaolu Zhang; Leo Feferman; David Johnson; Frank C Tortella; Marina Guizzetti; Joanne K Tobacman
Journal:  J Neurochem       Date:  2015-06-28       Impact factor: 5.372

Review 3.  Systems biology approaches for discovering biomarkers for traumatic brain injury.

Authors:  Jacob D Feala; Mohamed Diwan M Abdulhameed; Chenggang Yu; Bhaskar Dutta; Xueping Yu; Kara Schmid; Jitendra Dave; Frank Tortella; Jaques Reifman
Journal:  J Neurotrauma       Date:  2013-07-01       Impact factor: 5.269

Review 4.  Cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Anne M Fagan; David M Holtzman
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

5.  Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury.

Authors:  Andrew K Ottens; Liliana Bustamante; Erin C Golden; Changping Yao; Ronald L Hayes; Kevin K W Wang; Frank C Tortella; Jitendra R Dave
Journal:  J Neurotrauma       Date:  2010-10-09       Impact factor: 5.269

6.  Tau protein and beta-amyloid(1-42) CSF levels in different phenotypes of Parkinson's disease.

Authors:  Hana Přikrylová Vranová; Jan Mareš; Petr Hluštík; Martin Nevrlý; David Stejskal; Jana Zapletalová; Radko Obereigneru; Petr Kaňovský
Journal:  J Neural Transm (Vienna)       Date:  2011-09-04       Impact factor: 3.575

Review 7.  Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury.

Authors:  Pramod K Dash; Jing Zhao; Georgene Hergenroeder; Anthony N Moore
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

8.  Cerebrospinal fluid biomarkers for dementia with lewy bodies.

Authors:  Elizabeta B Mukaetova-Ladinska; Rachael Monteith; Elaine K Perry
Journal:  Int J Alzheimers Dis       Date:  2010-10-17

9.  P43/pro-EMAPII: a potential biomarker for discriminating traumatic versus ischemic brain injury.

Authors:  Changping Yao; Anthony J Williams; Andrew K Ottens; X-C May Lu; Ming Cheng Liu; Ronald L Hayes; Kevin K Wang; Frank C Tortella; Jitendra R Dave
Journal:  J Neurotrauma       Date:  2009-08       Impact factor: 5.269

10.  Microglial Inflammasome Activation in Penetrating Ballistic-Like Brain Injury.

Authors:  Stephanie W Lee; Shyam Gajavelli; Markus S Spurlock; Cody Andreoni; Juan Pablo de Rivero Vaccari; M Ross Bullock; Robert W Keane; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2018-04-02       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.